Background on Sun Pharma and its Relevance
Sun Pharmaceutical Industries Ltd., an Indian-origin pharmaceutical company, has been identified by the Mexican federal government for failing to deliver medications as agreed. The company has asserted that it is fully prepared to distribute the required products, but faces logistical challenges in receiving and delivering them.
Government’s Allegations
During President Claudia Sheinbaum’s morning press conference on September 23, Eduardo Clark, the subsecretary of Integration and Development of the Health Sector, reported that Sun Pharma had breached 63.5% of its commitment to supply 71,848 medical products for the period 2025-2026. The company reportedly delivered only 26,240 pieces.
Sun Pharma’s Response
In a statement released on Friday, Sun Pharma emphasized that their primary obstacle is not product availability or capacity but rather logistical coordination issues faced by the public health sector. These issues include delivery scheduling delays, product rejections due to warehouse saturation, and order cancellations.
Carlos Estrada, the company’s general manager, clarified that their non-compliance is not due to a lack of products. Instead, Sun Pharma has 100% of the required medications and lots ready for immediate delivery in Mexico.
Call to Action and Capacity Confirmation
Sun Pharma urged authorities to streamline the allocation and efficient management of delivery appointments. The company confirmed its full capacity to deliver the 40,590 pending items “immediately.”
Estrada added, “Sun Pharma confirms the complete availability of its medications and requests urgent coordination to overcome shared logistical challenges with the Mexican government.”
Legal Background and Company History
Regarding the 2024 amparo obtained against a 40-month disqualification imposed by the former Secretary of Public Function, Sun Pharma explained that this legal action aimed to protect its operational capacity and ensure the supply of essential medications for Mexico’s healthcare system.
Sun Pharma has been a supplier to Mexico’s public health sector for over 20 years, providing medications in therapeutic areas such as psychiatry and oncology.
Key Questions and Answers
- What is the issue? Sun Pharma claims it has all medications ready for delivery but faces logistical challenges in receiving and distributing them due to public health sector coordination issues.
- What did the government report? The federal government stated that Sun Pharma has breached 63.5% of its commitment to supply 71,848 medical products for the period 2025-2026, delivering only 26,240 pieces.
- What is Sun Pharma’s response? The company claims that their primary obstacle is logistical coordination issues, not product availability or capacity.
- What legal action did Sun Pharma take? In 2024, Sun Pharma obtained an amparo against a 40-month disqualification to protect its operational capacity and ensure the supply of essential medications for Mexico’s healthcare system.
- How long has Sun Pharma been supplying Mexico’s public health sector? The company has been a supplier for over 20 years, providing medications in therapeutic areas like psychiatry and oncology.
